Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
The investment case for health technology in India is frequently overstated in one direction and understated in another
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
_Limited_256_384.jpg)
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The approved ANDA is therapeutically equivalent to the reference listed drug product
Subscribe To Our Newsletter & Stay Updated
